These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 932943)

  • 1. Nonspecific effect of bis(2-ethylhexyl) phthalate on hexobarbital sleep time.
    Swinyard EA; Woodhead JH; Petersen RV
    J Pharm Sci; 1976 May; 65(5):733-4. PubMed ID: 932943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of di-2-ethylhexyl phthalate on hexobarbital sleeping time in mice (author's transl)].
    Hidaka T; Suenaga N; Fukuda T
    Fukuoka Igaku Zasshi; 1977 Jul; 68(7):354-7. PubMed ID: 410722
    [No Abstract]   [Full Text] [Related]  

  • 3. Some pharmacologic and toxicologic effects of di-2-ethylhexyl phthalate (DEHP) and other plasticizers.
    Rubin RJ; Jaeger RJ
    Environ Health Perspect; 1973 Jan; 3():53-9. PubMed ID: 4704572
    [No Abstract]   [Full Text] [Related]  

  • 4. The absorption, metabolism and tissue distribution of di(2-ethylhexyl)phthalate in rats.
    Daniel JW; Bratt H
    Toxicology; 1974 Mar; 2(1):51-65. PubMed ID: 4823738
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of diphenylhydantoin on hexobarbital sleep time in mice and rats.
    Kemp JW; Tannhauser M; Swinyard EA
    Arch Int Pharmacodyn Ther; 1971 Sep; 193(1):37-47. PubMed ID: 5111324
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of drug metabolism. 3. Inhibition of hexobarbital metabolism in the intact rat and in the isolated perfused liver by 2-diethylaminoethyl 2,2-diphenylvalerate HC1 (SKF 525-A) and its N-deethylated derivatives.
    Stitzel RE; Anders MW; Mannering GJ
    Mol Pharmacol; 1966 Jul; 2(4):335-40. PubMed ID: 5968073
    [No Abstract]   [Full Text] [Related]  

  • 7. Hexobarbital action in rats with flavonoid-deficiency.
    Endell W; Seidel G
    Experientia; 1976 Sep; 32(9):1189-90. PubMed ID: 971760
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of exposure to lindane on drug metabolism: decreased hexobarbital sleeping-times and increased antipyrine disappearance rate in rats.
    Kolmodin-Hedman B; Alexanderson B; Sjöqvist F
    Toxicol Appl Pharmacol; 1971 Nov; 20(3):299-307. PubMed ID: 4109017
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of subchronic treatment with (-) 8 -trans-tetrahydrocannabinol ( 8 -THC) on food intake, body temperature, hexobarbital sleeping time and hexobarbital elimination in rats.
    Rating D; Broermann I; Honecker H; Kluwe S; Coper H
    Psychopharmacologia; 1972; 27(4):349-57. PubMed ID: 4648618
    [No Abstract]   [Full Text] [Related]  

  • 10. Stereoselective metabolism of the enantiomers of hexobarbital.
    Furner RL; McCarthy JS; Stitzel RE; Anders MW
    J Pharmacol Exp Ther; 1969 Oct; 169(2):153-8. PubMed ID: 5824599
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of the plasticiser di-2-ethylhexyl-phthalate on drug metabolising enzymes in the liver of uraemic rats.
    Leber HW; Uviss T; Prenter A
    Proc Eur Dial Transplant Assoc; 1979; 16():232-7. PubMed ID: 548985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of urea on hexobarbital and antipyrine disposition in rats.
    Valentovic M; Bachmann K
    Pharmacology; 1980; 21(3):167-74. PubMed ID: 7413718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on some possible mechanisms of potentiation of hexobarbital hypnosis by pilocarpine, muscarine and arecoline.
    Tsujimoto A; Doi T; Ikeda M; Nishikawa T
    Arch Int Pharmacodyn Ther; 1974 Dec; 212(2):264-73. PubMed ID: 4447408
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics of the enantiomers of hexobarbital studied in the same intact rat and in the same isolated perfused rat liver.
    Breimer DD; van Rossum JM
    Eur J Pharmacol; 1974 May; 26(2):321-30. PubMed ID: 4853606
    [No Abstract]   [Full Text] [Related]  

  • 15. Factors affecting the metabolism and response to hexobarbital.
    Furner RL; Gram TE; Stitzel RE
    Pharmacology; 1969; 2(3):181-9. PubMed ID: 5346144
    [No Abstract]   [Full Text] [Related]  

  • 16. Increase of hexobarbital sleeping time and inhibition of drug metabolism by the major metabolite of diphenylhydantoin.
    Stavchansky SA; Lubawy WC; Kostenbauder HB
    Life Sci; 1974 Apr; 14(8):1535-9. PubMed ID: 4829543
    [No Abstract]   [Full Text] [Related]  

  • 17. Inhibition of hepatic drug metabolism by cyclic 3',5'-adenosine monophosphate.
    Weiner M; Buterbaugh GG; Blake DA
    Res Commun Chem Pathol Pharmacol; 1972 Mar; 3(2):249-63. PubMed ID: 4372659
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of low protein diet on sleeping time and on the metabolism of hexobarbital in rats.
    Czyzewska-Szafran H; Lastowska K; Obojska K; Wutkiewicz M
    Pol J Pharmacol Pharm; 1975; 27(6):625-30. PubMed ID: 1208235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 1,1,1-trichloroethane administered by different routes and in different solvents on barbiturate hypnosis and metabolism in mice.
    Shan HC; Lal H
    J Toxicol Environ Health; 1976 May; 1(5):807-16. PubMed ID: 1271486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of subacute intoxication with some heavy metals on hexobarbital sleep and metabolism.
    Stoytchev T; Krotev L
    Acta Physiol Pharmacol Bulg; 1978; 4(3):29-35. PubMed ID: 751449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.